Cure51

Company that provides clinical and molecular database of exceptional cancer survivors

placeParis, Ile De France, France calendar_todayFounded 2021 language cure51.com

Social engagement

Social engagement: 8.8K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; lead investors include Sofinnova Partners.

Investor typeCountShare
Venture capital467%
Other / undisclosed233%

Recent activity

18 Jun 2026
Event
4th Single Cell & Spatial Day in Basel
11 Jun 2026
Event
Coure51
2 Jun 2026
Partnership
ICAPAvignon
Coming soon